Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jost

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
Haematologica|May 11, 2023
Transcriptomic profiling does not refine mastocytosis diagnosisLars Buschhorn, Dorett I Odoni, Johanna Geuder, et al.
Frontiers in Neurology|September 20, 2023
Evaluation of intracranial stenting in a simulated training and assessment environment for neuroendovascular proceduresAnna A Kyselyova, Andreas M Frölich, Maxim Bester, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLCNikolaus John, Verena Schlintl, Teresa Sassmann, et al.
Nature|July 24, 2009
XIAP discriminates between type I and type II FAS-induced apoptosisPhilipp J Jost, Stephanie Grabow, Daniel Gray, et al.
Cancer Research|February 12, 2020
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CMLTom Hähnel, Christoph Baldow, Joëlle Guilhot, et al.
International Journal of Molecular Sciences|March 29, 2023
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST)Michael Rassner, Silvia Waldeck, Marie Follo, et al.
European Journal of Haematology|February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIMFlorian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Cancers|June 2, 2021
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment IntensityChristoph Suppan, Florian Posch, Hannah Deborah Mueller, et al.
Immunity|January 3, 2009
Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and BimThomas Kaufmann, Philipp J Jost, Marc Pellegrini, et al.
Cell Death & Disease|September 22, 2019
TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAPJanin Knop, Lisanne M Spilgies, Stefanie Rufli, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Haematologica|May 11, 2023
Transcriptomic profiling does not refine mastocytosis diagnosisLars Buschhorn, Dorett I Odoni, Johanna Geuder, et al.
Frontiers in Neurology|September 20, 2023
Evaluation of intracranial stenting in a simulated training and assessment environment for neuroendovascular proceduresAnna A Kyselyova, Andreas M Frölich, Maxim Bester, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLCNikolaus John, Verena Schlintl, Teresa Sassmann, et al.
Nature|July 24, 2009
XIAP discriminates between type I and type II FAS-induced apoptosisPhilipp J Jost, Stephanie Grabow, Daniel Gray, et al.
Cancer Research|February 12, 2020
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CMLTom Hähnel, Christoph Baldow, Joëlle Guilhot, et al.
International Journal of Molecular Sciences|March 29, 2023
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST)Michael Rassner, Silvia Waldeck, Marie Follo, et al.
European Journal of Haematology|February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIMFlorian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Cancers|June 2, 2021
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment IntensityChristoph Suppan, Florian Posch, Hannah Deborah Mueller, et al.
Immunity|January 3, 2009
Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and BimThomas Kaufmann, Philipp J Jost, Marc Pellegrini, et al.
Cell Death & Disease|September 22, 2019
TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAPJanin Knop, Lisanne M Spilgies, Stefanie Rufli, et al.
Pageof 21